A comprehensive view of Over-the-Counter (OTC) Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Dollar General forms Healthcare Advisory Panel, a body of experts that will help explore ways to expand company's health care offerings; news comes after naming Dr. Albert Wu from McKinsey to newly created post of VP, chief medical officer last July
Published: August 04, 2022 by Supermarket News
51% of US adults unlikely to use prescription drugs, OTC products after a recall, even if issue is fixed; 80% of adults unlikely to trust a manufacturer after warning letter from FDA, 47% unlikely to ever use a product from manufacturer again: Qualio
Published: August 03, 2022 by PR Newswire
FDA announces Family Dollar retail stores recall of wide variety of OTC medications, personal care items nationwide because products may have been stored outside labeled temperature requirements; recall involves 425 individual products
Published: August 01, 2022 by The Woodward News
Global OTC drug market projected to grow to US$410.5B by 2030, with CAGR growth of 8.2% from 2022-2030; growth driven by increased focus on maintaining health, use of OTC drugs to treat common illnesses
Published: August 01, 2022 by Financial Services Monitor Worldwide
Teva swings to Q2 GAAP operating loss of US$949.0M from US$582.0M income last year, with revenues down 3% from a year ago to US$3.8B; generic, OTC business benefitted from easing of COVID-19 restrictions and firm reaches agreement in opioids litigation
Published: July 28, 2022 by ENP Newswire

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count